CN107557333B - 一种用于细胞治疗的新抗原呈递细胞的制备方法 - Google Patents
一种用于细胞治疗的新抗原呈递细胞的制备方法 Download PDFInfo
- Publication number
- CN107557333B CN107557333B CN201710958123.XA CN201710958123A CN107557333B CN 107557333 B CN107557333 B CN 107557333B CN 201710958123 A CN201710958123 A CN 201710958123A CN 107557333 B CN107557333 B CN 107557333B
- Authority
- CN
- China
- Prior art keywords
- cell
- antigen
- preparation
- rpmi
- pbmc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710958123.XA CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710958123.XA CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107557333A CN107557333A (zh) | 2018-01-09 |
CN107557333B true CN107557333B (zh) | 2018-07-31 |
Family
ID=60986056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710958123.XA Active CN107557333B (zh) | 2017-10-16 | 2017-10-16 | 一种用于细胞治疗的新抗原呈递细胞的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107557333B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109136276A (zh) * | 2018-09-30 | 2019-01-04 | 北京鼎成肽源生物技术有限公司 | 一种rfft2细胞的构建方法 |
CN109295106B (zh) * | 2018-09-30 | 2020-07-24 | 北京鼎成肽源生物技术有限公司 | 一种hafft1细胞 |
CN109294997B (zh) * | 2018-09-30 | 2020-09-25 | 北京鼎成肽源生物技术有限公司 | 一种lrfft1细胞 |
CN109182383A (zh) * | 2018-09-30 | 2019-01-11 | 北京鼎成肽源生物技术有限公司 | 一种rfft1细胞的构建方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1297017T3 (da) * | 2000-06-19 | 2012-09-17 | Dana Farber Cancer Inst Inc | Sammensætninger og fremgangsmåder med monoklonale og polyklonale antistoffer, der er specifikke for T-cellesubpopulationer |
WO2003012085A1 (en) * | 2001-07-30 | 2003-02-13 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antigen presenting cells, method for their preparation and their use for cancer vaccines |
AU2003233978A1 (en) * | 2002-04-19 | 2003-11-03 | Filippo Belardelli | Rapid generation of activated mononuclear antigen presenting cells from monocytes |
CN103301449B (zh) * | 2012-11-02 | 2016-01-13 | 泰州市数康生物技术有限公司 | 一种大规模培养树突状细胞疫苗的制备方法及其应用 |
CN105112369A (zh) * | 2015-08-25 | 2015-12-02 | 北京康爱瑞浩生物科技股份有限公司 | 具有持续抗肿瘤活性的ctl细胞制剂及其制备方法 |
EP3397263B1 (en) * | 2015-12-30 | 2023-09-20 | Celgene Corporation | T lymphocyte production methods and t lymphocytes produced thereby |
-
2017
- 2017-10-16 CN CN201710958123.XA patent/CN107557333B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107557333A (zh) | 2018-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107557333B (zh) | 一种用于细胞治疗的新抗原呈递细胞的制备方法 | |
CN105602992B (zh) | 一种基于复制缺陷性重组慢病毒的car-t转基因载体及其构建方法和应用 | |
Zuo et al. | Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses | |
CN101824400B (zh) | 一种放大增殖抗原特异性t细胞的方法 | |
CN105950664B (zh) | 一种靶向cd123的复制缺陷性重组慢病毒car-t转基因载体及其构建方法和应用 | |
CN109097402A (zh) | 一种重组载体CAR-CD244-antiCD19的制备方法 | |
Posch et al. | Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes | |
Ayinde et al. | SAMHD1 limits HIV-1 antigen presentation by monocyte-derived dendritic cells | |
CN105950663B (zh) | 一种靶向cd30的复制缺陷性重组慢病毒car-t转基因载体及其构建方法和应用 | |
US10912798B2 (en) | Methods for treating an infectious or neoplastic disease | |
CN105709221A (zh) | 用于预防和/或治疗人中的hiv疾病的药物组合物 | |
Sremac et al. | SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation | |
JP6029677B2 (ja) | 腫瘍免疫療法のためのワクチン | |
CN117286100A (zh) | 一种基于DCline诱导细胞毒性T细胞用于治疗病毒感染的方法 | |
Liu et al. | Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰ | |
WO2021032179A1 (zh) | 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用 | |
Song et al. | Ubiquitin‑modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro | |
Villamide-Herrera et al. | Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo | |
CN111057683A (zh) | 一种鸡胚接种用病毒稀释液及其制备方法和应用 | |
CN107254440A (zh) | Cd4阳性th17t细胞培养方法 | |
Sugita et al. | Fusogenic liposome can be used as an effective vaccine carrier for peptide vaccination to induce cytotoxic T lymphocyte (CTL) response | |
JP6636915B2 (ja) | ユビキチニル化タンパク質 | |
Padula et al. | Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses | |
Freer et al. | Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus | |
CN113754779A (zh) | DC细胞表达的mesothelin-ODC422-461融合蛋白及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181105 Address after: 102206 Room 101, 7 building, 20 Life Science Garden Road, Huilongguan, Changping District, Beijing. Co-patentee after: Jiao Shunchang Patentee after: BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO., LTD. Address before: 102206 room 316-26, B block 1, 29 life Garden Road, Changping District, Beijing. Patentee before: BEIJING DINGCHENG TAIYUAN BIOTECHNOLOGY CO., LTD. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Shunchang Inventor after: Zhang Rong Inventor after: Zhang Tianfu Inventor before: Zhang Rong Inventor before: Zhang Tianfu |